¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"fibrin"¿¡ ´ëÇÑ ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
fibrinolytic p. purpura secondary to and accompanied by increased fibrinolytic activity of the blood.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
fibrin-fibrinogen degradation products A group of soluble protein fragments produced by the proteolytic action of plasmin on fibrin or fibrinogen. These products impair the hemostatic process and are a major cause of hemorrhage in intravascular
Ãâó:
fibrinolytic t. the use of fibrinolytic agents (prourokinase, streptokinase, t-plasminogen activator, u-plasminogen activator) to lyse thrombi in patients with acute peripheral arterial occlusion, deep venous thrombosis, pulmonary embolism, and acute myocardial infarction. Called also thrombolytic t.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
fibrinoid change Alteration in connective tissues in response to immune reactions. The tissue becomes swollen, homogeneous, and bandlike.
Ãâó:
fibrinoplatelet composed of fibrin and platelets, as a blood clot.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÅëÇÕ°Ë»ö ¿Ï·á